Skip to main content

Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes.

Publication ,  Journal Article
Hughes, BL; Clifton, RG; Rouse, DJ; Saade, GR; Dinsmoor, MJ; Reddy, UM; Pass, R; Allard, D; Mallett, G; MacPherson, C; Wapner, R; Metz, T ...
Published in: N Engl J Med
November 9, 2023

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

November 9, 2023

Volume

389

Issue

19

Start / End Page

1822 / 1824

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Pregnancy Complications, Infectious
  • Pregnancy
  • Immunoglobulins, Intravenous
  • Immunoglobulins
  • Humans
  • General & Internal Medicine
  • Female
  • Cytomegalovirus Infections
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hughes, B. L., Clifton, R. G., Rouse, D. J., Saade, G. R., Dinsmoor, M. J., Reddy, U. M., … Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. (2023). Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes. N Engl J Med, 389(19), 1822–1824. https://doi.org/10.1056/NEJMc2308286
Hughes, Brenna L., Rebecca G. Clifton, Dwight J. Rouse, George R. Saade, Mara J. Dinsmoor, Uma M. Reddy, Robert Pass, et al. “Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes.N Engl J Med 389, no. 19 (November 9, 2023): 1822–24. https://doi.org/10.1056/NEJMc2308286.
Hughes BL, Clifton RG, Rouse DJ, Saade GR, Dinsmoor MJ, Reddy UM, et al. Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes. N Engl J Med. 2023 Nov 9;389(19):1822–4.
Hughes, Brenna L., et al. “Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes.N Engl J Med, vol. 389, no. 19, Nov. 2023, pp. 1822–24. Pubmed, doi:10.1056/NEJMc2308286.
Hughes BL, Clifton RG, Rouse DJ, Saade GR, Dinsmoor MJ, Reddy UM, Pass R, Allard D, Mallett G, MacPherson C, Wapner R, Metz T, Goodnight WH, Tita ATN, Costantine MM, Swamy GK, Heyborne KD, Chien EK, Chauhan SP, El-Sayed YY, Casey BM, Parry S, Simhan HN, Napolitano PG, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes. N Engl J Med. 2023 Nov 9;389(19):1822–1824.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

November 9, 2023

Volume

389

Issue

19

Start / End Page

1822 / 1824

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Pregnancy Complications, Infectious
  • Pregnancy
  • Immunoglobulins, Intravenous
  • Immunoglobulins
  • Humans
  • General & Internal Medicine
  • Female
  • Cytomegalovirus Infections
  • 42 Health sciences